Fosun International’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-761,538
Closed -$103M 72
2022
Q3
$103M Sell
761,538
-242,102
-24% -$37M 10.98% 2
2022
Q2
$150M Sell
1,003,640
-50,000
-5% -$7.64M 20.73% 1
2022
Q1
$180M Sell
1,053,640
-527,137
-33% -$88.6M 15.52% 1
2021
Q4
$408M Hold
1,580,777
23.29% 1
2021
Q3
$432M Hold
1,580,777
22.08% 1
2021
Q2
$354M Buy
+1,580,777
New +$298M 21.01% 1

Other funds holding BNTX

Fosun International's BNTX Position: Q4 2022 in Review

Fosun International sold out of BioNTech (BNTX) in Q4 2022, closing a stake of 761,538 shares — an estimated $103M sold.

Fosun International first reported a position in BNTX in Q2 2021 and held it in 6 quarters. The position peaked at $432M in Q3 2021. 320 funds tracked by Wall St. Rank hold BNTX as of Q4 2022.

  • Fosun International reported no remaining BioNTech position as of Q4 2022 after selling out during the quarter.
  • Fosun International sold 761,538 BioNTech shares in Q4 2022, an estimated $103M.
  • Fosun International first reported a position in BioNTech in Q2 2021 and held it in 6 quarters.
  • Fosun International's BioNTech position peaked at $432M in Q3 2021.
  • 320 funds tracked by Wall St. Rank held BioNTech as of Q4 2022.

Based on Fosun International's 13F filing for Q4 2022, filed 10 Feb 2023.